Prof. Dr. Felicitas Hitz
Stv. Chefärztin
Leitung Netzwerk
Leitung Bildung
Leitende(r) Arzt/Ärztin
Medizinische Onkologie und Hämatologie · Dept. I
Outcome of mantle cell lymphoma patients treated at a single institution over the past decade
Hitz F, Diem S, Haile S, ess s, Cerny T, Mey U. Outcome of mantle cell lymphoma patients treated at a single institution over the past decade. Hematol Oncol 2013
11.12.2013Outcome of mantle cell lymphoma patients treated at a single institution over the past decade
11.12.2013Hematol Oncol 2013
Hitz Felicitas, Diem Stefan, Haile Sarah, ess silvia, Cerny Thomas, Mey Ulrich
Diagnosis and treatment of mantle cell lymphoma
Hitz F, Bargetzi M, Cogliatti S, Lohri A, Taverna C, Renner C, Mey U. Diagnosis and treatment of mantle cell lymphoma. Swiss Med Wkly 2013; 143:w13868.
13.11.2013Diagnosis and treatment of mantle cell lymphoma
13.11.2013Swiss Med Wkly 2013; 143:w13868
Hitz Felicitas, Bargetzi Mario, Cogliatti Sergio, Lohri Andreas, Taverna Christian, Renner Christoph, Mey Ulrich
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction
Jörger M, Huitema A, Koeberle D, Rosing H, Beijnen J, Hitz F, Cerny T, Schellens J, Gillessen Sommer S. Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction. Cancer Chemother Pharmacol 2013; 73:113-24.
29.10.2013Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction
29.10.2013Cancer Chemother Pharmacol 2013; 73:113-24
Jörger Markus, Huitema A D R, Koeberle D, Rosing H, Beijnen J H, Hitz Felicitas, Cerny Thomas, Schellens J H M, Gillessen Sommer Silke
Posterior reversible encephalopathy syndrome during induction chemotherapy for acute myeloid leukaemia
Silzle T, Glaser-Gallion N, Hitz F. Posterior reversible encephalopathy syndrome during induction chemotherapy for acute myeloid leukaemia. Eur J Haematol 2013; 92:90.
17.09.2013Posterior reversible encephalopathy syndrome during induction chemotherapy for acute myeloid leukaemia
17.09.2013Eur J Haematol 2013; 92:90
Silzle Tobias, Glaser-Gallion Nicola, Hitz Felicitas
The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients
Clough-Gorr K, Noti L, Brauchli P, Cathomas R, Fried M, Roberts G, Stuck A, Hitz F, Mey U. The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients. BMC Med Inform Decis Mak 2013; 13:93.
23.08.2013The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients
23.08.2013BMC Med Inform Decis Mak 2013; 13:93
Clough-Gorr Kerri M, Noti Lea, Brauchli Peter, Cathomas Richard, Fried Marius R, Roberts Gillian, Stuck Andreas E, Hitz Felicitas, Mey Ulrich
Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer
Hitz F, Ribi K, Li Q, Klingbiel D, Cerny T, Koeberle D. Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer. Support Care Cancer 2013; 21:3085-93.
05.07.2013Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancer
05.07.2013Support Care Cancer 2013; 21:3085-93
Hitz Felicitas, Ribi Karin, Li Qiyu, Klingbiel Dirk, Cerny Thomas, Koeberle Dieter
Management of elderly patients with advanced non-small cell lung cancer: a single-center experience
Früh M, Besrour H, Gillessen Sommer S, Jörger M, Hitz F, Savidan A, Cerny T, Ess S. Management of elderly patients with advanced non-small cell lung cancer: a single-center experience. Chemotherapy 2013; 59:42-50.
02.07.2013Management of elderly patients with advanced non-small cell lung cancer: a single-center experience
02.07.2013Chemotherapy 2013; 59:42-50
Früh Martin, Besrour H, Gillessen Sommer Silke, Jörger Markus, Hitz Felicitas, Savidan A, Cerny Thomas, Ess S
Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
Schallegger K, Brügge D, Hitz F, Hundsberger T, Cathomas R, Plasswilm L (2012). Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis.
19.04.2012Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
19.04.2012SASRO 2012
Schallegger K, Brügge Detlef, Hitz Felicitas, Hundsberger Thomas, Cathomas R, Plasswilm Ludwig
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma
Renner C, Lohri A, Gyan E, Biaggi C, Cogliatti S, Bertoni F, Ghielmini M, Brauchli P, Ketterer N, Bouabdallah K, Trojan A, Zinzani P, Gressin R, Klingbiel D, Dietrich P, Hitz F, Bargetzi M, Mingrone W, Martinelli G, Swiss SAKK and French GOELAMS group from European Mantle Cell Lymphoma Network. A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica 2012; 97:1085-91.
07.02.2012A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma
07.02.2012Haematologica 2012; 97:1085-91
Renner Christoph, Lohri Andreas, Gyan Emmanuel, Biaggi Christine, Cogliatti Sergio B., Bertoni Francesco, Ghielmini Michele, Brauchli Peter, Ketterer Nicolas, Bouabdallah Krimo, Trojan Andreas, Zinzani Pier Luigi, Gressin Rémy, Klingbiel Dirk, Dietrich Pierre-Yves, Hitz Felicitas, Bargetzi Mario, Mingrone Walter, Martinelli Giovanni, Swiss SAKK and French GOELAMS group from European Mantle Cell Lymphoma Network
Athrombogenic coating of long-term venous catheter for cancer patients: a prospective, randomised, double-blind trial
Hitz F, Klingbiel D, Omlin A, Riniker S, Zerz A, Cerny T. Athrombogenic coating of long-term venous catheter for cancer patients: a prospective, randomised, double-blind trial. Ann Hematol 2011; 91:613-20.
29.09.2011Athrombogenic coating of long-term venous catheter for cancer patients: a prospective, randomised, double-blind trial
29.09.2011Ann Hematol 2011; 91:613-20
Hitz Felicitas, Klingbiel Dirk, Omlin Aurelius, Riniker Salome, Zerz Andreas, Cerny Thomas
[A Rare Cause of a Cervical Lymphadenopathy.]
Hinder R, Hitz F, Brugnolaro C, Stöckli S. [A Rare Cause of a Cervical Lymphadenopathy.]. Praxis (Bern 1994) 2011; 100:105-108.
19.01.2011[A Rare Cause of a Cervical Lymphadenopathy.]
19.01.2011Praxis (Bern 1994) 2011; 100:105-108
Hinder R, Hitz Felicitas, Brugnolaro C, Stöckli Sandro
A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03
Hitz F, Ghielmini M, Zimmermann D, Bertoni F, Cogliatti S, Peterson J, Simcock M, Mingrone W, von Moos R, Zucca E, Martinelli G, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. Hematological oncology 2009; 27:154-9.
01.09.2009A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03
01.09.2009Hematological oncology 2009; 27:154-9
Hitz Felicitas, Ghielmini M, Zimmermann D R, Bertoni F, Cogliatti Sergio B., Peterson J, Simcock M, Mingrone W, von Moos R, Zucca E, Martinelli G, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases
Beyer V, van Melle G, Schmidt P, Schanz U, Laurencet F, Chapuis B, Hess U, Hitz F, Gregor M, Pugin P, Tobler A, Solenthaler M, Bougeon-Mamin S, Cabrol C, Parlier V, Mühlematter D, Jotterand M. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases. Cancer genetics and cytogenetics 2005; 160:97-119.
15.07.2005Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases
15.07.2005Cancer genetics and cytogenetics 2005; 160:97-119
Beyer Valérie, van Melle Guy, Schmidt Pierre-Michel, Schanz Urs, Laurencet France, Chapuis Bernard, Hess Urs, Hitz Felicitas, Gregor Michael, Pugin Paul, Tobler Andreas, Solenthaler Max, Bougeon-Mamin Sandrine, Cabrol Christine, Parlier Valérie, Mühlematter Dominique, Jotterand Martine
[Mabthera for treatment of malignant lymphoma]
Cerny T, Hitz F, Gillessen Sommer S. [Mabthera for treatment of malignant lymphoma]. Therapeutische Umschau. Revue thérapeutique 2004; 61:379-83.
01.06.2004[Mabthera for treatment of malignant lymphoma]
01.06.2004Therapeutische Umschau. Revue thérapeutique 2004; 61:379-83
Cerny Thomas, Hitz Felicitas, Gillessen Sommer Silke